ALPS (ALPS Group) Moat Score: 1/10 (As of Jul. 16, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ALPS ALPS Group Inc ALPS
10 GF Score
Price $0.48
! 2 Warning Signs
View Full Analysis

What is ALPS Group Moat Score?

ALPS Group ALPS -2.73% 10 Moat Score is 1 as of Jul. 16, 2026. GuruFocus rates ALPS with a GF Score™ of 10/100. The stock has 2 warning signs investors should review. Among 1,396 Biotechnology companies, ALPS Group ranks worse than 52.36% on this metric.

ALPS Group has the Moat Score of 1, which implies that the company might have No Moat - Very weak/transient advantages.

ALPS Group has No Moat: ALPS Group lacks significant competitive advantages, with no strong brand, intellectual property, or market leadership.

Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more.

The company's Moat Score is based on these criteria:

1. Market leadership and sustainable market share
2. Network effects and significant customer switching costs
3. Valuable intellectual property and patents
4. Strong brand strength and deep customer loyalty
5. Durable cost advantages (e.g., economies of scale, proprietary technology)
6. Significant regulatory barriers and exclusive licenses
7. Superior distribution network
8. Strong and sustainable pricing power
9. Consistent and impactful innovation and R&D capabilities

Based on the research, GuruFocus believes ALPS Group might have No Moat - Very weak/transient advantages.

ALPS Group  (NAS:ALPS) Moat Score Explanation

The Moat Score ranges from 0 to 10, with 10 as the highest. GuruFocus divided Moat Score into following 8 categories:

Moat Score Moat Level
10Wide Moat - Exceptionally dominant and durable wide moat
8 - 9Wide Moat - Clear and robust wide moat
7Wide Moat - Entry-level wide moat, clearly possessing durable advantages
6Narrow Moat - Strong narrow moat, clearly distinguishable but not wide
5Narrow Moat - Solid narrow moat
4Narrow Moat - Discernible but modest moat
1 - 3No Moat - Very weak/transient advantages
0No Moat - No discernible moat

ALPS Group Moat Score Related Terms

ALPS vs CUE, AARD, KLRS: Moat Score Comparison

For the Biotechnology subindustry, ALPS Group's Moat Score, along with its competitors' market caps and Moat Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

ALPS Group Moat Score vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, ALPS Group's Moat Score distribution charts can be found below:

* The bar in red indicates where ALPS Group's Moat Score falls into.


ALPS
10GF Score
ALPS Group Inc ALPS
Moat Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Moat Score →
What does a Moat Score of 1 mean?
ALPS Group (ALPS) has a Moat Score of 1 as of Jul. 16, 2026. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. According to the industry distribution chart, ALPS Group ranks #731 out of 1396 companies in the Biotechnology industry, placing it in the top 52.4%.
Is ALPS Group's Moat Score too high?
ALPS Group's current Moat Score is 1. The Biotechnology industry median Moat Score is 2.00. ALPS Group's value of 1 is 50% below this industry median. Based on the distribution chart, ALPS Group ranks #731 out of 1396 companies in the Biotechnology industry, which is below the industry midpoint. Overall, ALPS Group has a GF Score™ of 10/100, reflecting its overall financial health beyond just this single metric.
How does ALPS Group's Moat Score compare to CUE and AARD?
According to the Biotechnology industry distribution chart, ALPS Group ranks #731 out of 1396 companies for Moat Score. This places ALPS Group in the lower half of its industry. The industry median Moat Score is 2.00. ALPS Group's value of 1 is 50% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Moat Score for a Biotechnology company?
The median Moat Score among Biotechnology companies is 2.00, based on 1,396 companies in the industry. Companies in the top quartile (top 25%) have a Moat Score significantly above this median, while those in the bottom quartile fall well below. However, Moat Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. ALPS Group's current Moat Score of 1 is 50% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Moat Score mean?
A high Moat Score can signal that a stock is expensive relative to its fundamentals. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. For the Biotechnology industry, the median Moat Score is 2.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. ALPS Group's current Moat Score is 1. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ALPS Group stock overvalued right now?
ALPS Group (ALPS) has a current Moat Score of 1. The current Moat Score is 1 and 50% below the Biotechnology industry median of 2.00. ALPS Group's overall GF Score™ is 10/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Moat Score calculated?
Moat Score is calculated from a company's financial statements. For ALPS Group (ALPS), the current Moat Score is 1 as of Jul. 16, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

ALPS Group Business Description

Address Jalan 1/68th Floor, Off Jalan Tun Razak, The ICON, East Wing Tower, Level 18-01 & 18-02, No.1, Kuala Lumpur, MYS, 50400
ALPS Group Inc is a fully integrated platform encompassing biotechnology research, medical, and wellness services specializing in predictive, precision and preventive health management. It aims to provide its clientele with access to DNA and mRNA sequencing, cellular therapy, as well as wellness and anti-aging products and services.
10GF Score

Get the complete analysis for ALPS

Moat Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.48
Price